发明名称 |
Heteroannelated anthraquinone derivatives for inhibiting cancers |
摘要 |
Methods and pharmaceutical compositions for treating cancer utilizing compounds characterized by the following structure:;
and their pharmaceutically acceptable salts. |
申请公布号 |
US8772321(B2) |
申请公布日期 |
2014.07.08 |
申请号 |
US201113325852 |
申请日期 |
2011.12.14 |
申请人 |
National Defense Medical Center |
发明人 |
Huang Hsu-Shan;Chen Tsung-Chih;Cha Tai-Lung |
分类号 |
A61K31/428;C07D285/14 |
主分类号 |
A61K31/428 |
代理机构 |
Muncy, Geissler, Olds & Lowe, P.C. |
代理人 |
Muncy, Geissler, Olds & Lowe, P.C. |
主权项 |
1. A method for treating cancer in a mammalian subject in need thereof, consisting of:
inducing apoptosis, inhibiting cancer cell proliferation, or inhibiting telomerase activity in cancer cells of the mammalian subject by administering to the mammalian subject an effective amount of a pharmaceutical composition comprising:
a compound having the formula (I): or pharmaceutically acceptable salts thereof; anda pharmaceutically acceptable carrier, a diluent, an excipient, or a combination thereof. |
地址 |
Taipei TW |